VVOS Stock Analysis: Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells
- Latest close
- $0.16
- 20-day change
- -41.51%
- Trend state
- LEAN BEAR
- Classification
- Healthcare · Medical - Devices
Market context
Vivos Therapeutics, Inc. moved -41.51% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BEAR.
Latest report
The latest cached company filing period (FY2025 · $17.4M revenue · -$21.2M net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Growth is currently the strongest dimension at 2.8/6, while Profitability is the lowest at 0.5/6. Scores are comparative research signals, not forecasts.